. | Quartiles of simplified food pattern score . | . | . | . | P (χ2 test for trend) . | |||
---|---|---|---|---|---|---|---|---|
. | 1 . | 2 . | 3 . | 4 . | . | |||
Demographics and design characteristics | ||||||||
Age (years) | 56.4 ± 8.4 | 55.4 ± 8.3 | 53.7 ± 8.2 | 53.2 ± 8.6 | 0.0001 | |||
Male sex (%) | 42.3 | 38.6 | 42.3 | 49.1 | 0.1625 | |||
Female sex (%) | 57.7 | 61.4 | 57.7 | 50.9 | 0.1625 | |||
Non-Hispanic white (%) | 41.4 | 47.7 | 38.2 | 33.6 | 0.0221 | |||
Non-Hispanic black (%) | 51.3 | 31.4 | 16.4 | 4.6 | <0.0001 | |||
Hispanic (%) | 7.3 | 20.9 | 45.4 | 61.8 | <0.0001 | |||
Normal glucose tolerance (%) | 66.8 | 62.7 | 68.6 | 67.7 | 0.5695 | |||
IGT (%) | 33.2 | 37.3 | 31.4 | 32.3 | 0.5695 | |||
Biomarkers | ||||||||
PAI-1 (ng/ml) | 15 ± 15 | 22 ± 28 | 24 ± 18 | 28 ± 20 | <0.0001 | |||
Fibrinogen (mg/dl) | 269 ± 52 | 277 ± 60 | 276 ± 56 | 280 ± 56 | 0.2127 | |||
BMI (kg/m2)* | 27.2 ± 4.3 | 28.6 ± 6.0 | 28.7 ± 5.8 | 29.3 ± 6.3 | 0.0025 | |||
Waist circumference (cm) | 87.6 ± 11.4 | 90.3 ± 13.2 | 90.5 ± 12.3 | 92.8 ± 12.8 | 0.0004 | |||
Fasting insulin (μU/ml)† | 14 ± 14 | 15 ± 13 | 16 ± 12 | 18 ± 20 | <0.0001 | |||
SI (min−1)(μU−1)(ml−1)(10−4)† | 2.5 ± 2.2 | 2.1 ± 1.8 | 2.2 ± 1.9 | 2.0 ± 1.8 | 0.0261 | |||
AIR (μU/ml/min)† | 57.5 ± 47.2 | 64.7 ± 52.6 | 70.1 ± 61.1 | 72.8 ± 64.8 | 0.0041 | |||
Triglycerides (mmol/l)† | 1.3 ± 0.8 | 1.5 ± 0.9 | 1.6 ± 1.1 | 1.6 ± 1.1 | 0.0006 | |||
HDL cholesterol (mmol/l)† | 1.3 ± 0.4 | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.1 ± 0.3 | <0.0001 |
. | Quartiles of simplified food pattern score . | . | . | . | P (χ2 test for trend) . | |||
---|---|---|---|---|---|---|---|---|
. | 1 . | 2 . | 3 . | 4 . | . | |||
Demographics and design characteristics | ||||||||
Age (years) | 56.4 ± 8.4 | 55.4 ± 8.3 | 53.7 ± 8.2 | 53.2 ± 8.6 | 0.0001 | |||
Male sex (%) | 42.3 | 38.6 | 42.3 | 49.1 | 0.1625 | |||
Female sex (%) | 57.7 | 61.4 | 57.7 | 50.9 | 0.1625 | |||
Non-Hispanic white (%) | 41.4 | 47.7 | 38.2 | 33.6 | 0.0221 | |||
Non-Hispanic black (%) | 51.3 | 31.4 | 16.4 | 4.6 | <0.0001 | |||
Hispanic (%) | 7.3 | 20.9 | 45.4 | 61.8 | <0.0001 | |||
Normal glucose tolerance (%) | 66.8 | 62.7 | 68.6 | 67.7 | 0.5695 | |||
IGT (%) | 33.2 | 37.3 | 31.4 | 32.3 | 0.5695 | |||
Biomarkers | ||||||||
PAI-1 (ng/ml) | 15 ± 15 | 22 ± 28 | 24 ± 18 | 28 ± 20 | <0.0001 | |||
Fibrinogen (mg/dl) | 269 ± 52 | 277 ± 60 | 276 ± 56 | 280 ± 56 | 0.2127 | |||
BMI (kg/m2)* | 27.2 ± 4.3 | 28.6 ± 6.0 | 28.7 ± 5.8 | 29.3 ± 6.3 | 0.0025 | |||
Waist circumference (cm) | 87.6 ± 11.4 | 90.3 ± 13.2 | 90.5 ± 12.3 | 92.8 ± 12.8 | 0.0004 | |||
Fasting insulin (μU/ml)† | 14 ± 14 | 15 ± 13 | 16 ± 12 | 18 ± 20 | <0.0001 | |||
SI (min−1)(μU−1)(ml−1)(10−4)† | 2.5 ± 2.2 | 2.1 ± 1.8 | 2.2 ± 1.9 | 2.0 ± 1.8 | 0.0261 | |||
AIR (μU/ml/min)† | 57.5 ± 47.2 | 64.7 ± 52.6 | 70.1 ± 61.1 | 72.8 ± 64.8 | 0.0041 | |||
Triglycerides (mmol/l)† | 1.3 ± 0.8 | 1.5 ± 0.9 | 1.6 ± 1.1 | 1.6 ± 1.1 | 0.0006 | |||
HDL cholesterol (mmol/l)† | 1.3 ± 0.4 | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.1 ± 0.3 | <0.0001 |
Data are % or means ± SD.
Sample size is n = 878.
Sample size is n = 831.